VERAXA Biotech, Quadira Biosciences form partnership on ADC development
Veraxa (former Velabs Therapeutics GmbH), a leading company in innovative ADC engineering and functional antibody screening, has entered into a partnership agreement with Quadira Biosciences AG, Zug, Switzerland, to jointly develop a suite of novel ADCs for the treatment of oncological conditions. The collaboration will leverage both the advantages of VERAXA’s advanced and proprietary position-true […]